Double blind placebo controlled trial of pulse treatment with methylprednisolone combined with disease modifying drugs in rheumatoid arthritis.

OBJECTIVE--To assess whether monthly treatment with intravenous methylprednisolone enhances or accelerates the effect of disease modifying drugs in patients with rheumatoid arthritis. DESIGN--A 12 month double blind, placebo controlled, multicentre trial in which patients with active rheumatoid arth...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Hansen, T M, Kryger, P, Elling, H, Haar, D, Kreutzfeldt, M, Ingeman-Nielsen, M W, Olsson, A T, Pedersen, C, Rahbek, A, Tvede, N
Format: Artigo
Jezik:Inglês
Izdano: 1990
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1663457/
https://ncbi.nlm.nih.gov/pubmed/2202458
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items